iRhythm Reports Smaller Than Expected Q2 Loss; Narrows Annual Sales Guidance
iRhythm Technologies Inc (NASDAQ:IRTC) posted a Q2 adjusted loss of $(0.79) compared to a loss of $(0.59) a year ago, beating…
Kazia Therapeutics Shares Jump On Interim Data From Paxalisib Combo Study In Brain Metastases
Kazia Therapeutics Limited (NASDAQ:KZIA) announced the presentation of new data from an ongoing phase 1 trial of paxalisib in combination with…
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
Insulet Corporation (NASDAQ:PODD) posted a Q2 net loss of $(35) million, or an EPS loss of $(0.50) compared to $(0.37)…
FDA Asks For Additional Study For Acadia’s Pimavanserin In Alzheimer’s-Associated Delusions
The FDA has issued a Complete Response Letter (CRL) to Acadia Pharmaceuticals Inc (NASDAQ:ACAD) regarding its supplemental marketing application for pimavanserin in…
Marker Therapeutics Shares Jump 60 Percent As FDA Announced Clearance To Blood Cell Cancer Study
The U.S. Food and Drug Administration (FDA) announced clearance to Marker Therapeutics’ (NASDAQ: MRKR) Investigational New Drug (IND) application for MT-601 for the treatment of patients with relapsed/refractory non-Hodgkin lymphoma.
US Officials Declare Health Emergency Over Monkeypox Outbreak As Cases Cross 6,000 Mark: Report
The Biden administration has officially declared monkeypox a public health emergency as cases continue to rise in the U.S., the Wall Street Jour
Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
Innovent Biologics Inc (OTC:IVBXF) and Sanofi SA (NASDAQ:SNY) have collaborated to develop and commercialize two Sanofi clinical-stage oncology assets – Phase 3 SAR408701…
Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition
Pfizer Inc (NYSE:PFE) announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM of PF-07265803, indicated…
Novavax Starts Late-Stage COVID-19 Vaccine Study In Children Below 11 Years
Novavax Inc (NASDAQ:NVAX) has initiated its Phase 2b/3 Hummingbird trial to evaluate the safety, effectiveness, and efficacy of two doses of…